gastazole 370 mg/g belsoleges paszta lovak számára a.u.v.
chanelle pharmaceuticals manufacturing ltd. - omeprazol - belsoleges paszta - omeprazole - ló
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - daganatellenes szerek - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
fenyokátrány lovak részére
tízpróba magyarország kereskedelmi kft. - fenyokátrány - külsoleges paszta - ló
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
remedy+ cerazinc krém kutyák, macskák és lovak részére
alpha-vet Állatgyógyászati kft. - krém - ló, kutya, macska
vey tosal 100 mg/ml + 0,05 mg/ml oldatos injekció lovak, szarvasmarhák, kutyák és macskák részére
veyx pharma gmbh - butafoszfán, cianokobalamin - oldatos injekció - other mineral products, combinations - szarvasmarha, ló, kutya, macska
lunsumio
roche registration gmbh - mosunetuzumab - lymphoma, follicularis - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
novaquin
le vet beheer b.v. - meloxikám - oxicams - lovak - gyulladás enyhítése és fájdalomcsillapítás mind akut, mind krónikus mozgásszervi betegségekben.
quadrisol
vetcool b.v. - vedaprofent - gyulladáscsökkentő, antirheumatic termékek - lovak - gyulladáscsökkentés és fájdalomcsillapítás a csont- és izomrendszeri megbetegedésekkel és lágyszöveti elváltozásokkal (traumás sérülések és sebészeti trauma). a várható sebészeti trauma esetén a quadrisol profilaktikusan adható legalább három órával az elektív műtét előtt.